[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Spiegelman, 1963 - Google Patents

Treatment of diabetes insipidus with synthetic vasopressin

Spiegelman, 1963

Document ID
8433509714171143300
Author
Spiegelman A
Publication year
Publication venue
JAMA

External Links

Snippet

THE CHRONIC NATURE of diabetes insipidus necessitates an indefinite course of treatment. Hormonal substitution is obviously the preferred form of therapy. Nevertheless some patients cannot tolerate the natural vasopressor substance or, for other reasons are …
Continue reading at jamanetwork.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators; Reciprocating systems for treatment of body fluids, e.g. single needle systems for haemofiltration, pheris
    • A61M1/28—Peritoneal dialysis; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285—Catheters therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
Day et al. Peritoneal dialysis in children. Review of 8 years' experience.
Spiegelman Treatment of diabetes insipidus with synthetic vasopressin
FELDMAN et al. Prolonged paresis following gallamine: a case report
Kurtzman Renal tubular acidosis: a constellation of syndromes
ALEXANDER et al. Chlorothiazide derivatives for diabetes insipidus?
Geiger et al. Acute pulmonary insufficiency: treatment in Vietnam casualties
Schreiner et al. The patient with chronic renal failure and surgery
KAISER et al. Intravenous infusion of ascitic fluid
Chew et al. Continuous atropine infusion in the management of organophosphorus insecticide poisoning
PARTENHEIMER et al. PRACTICAL CONTROL OF FLUID AND ELECTROLYTE BALANCE IN CARBON TETRACHLORIDE NEPHROSIS: Report of Cases
Litchman et al. Injuries to the medial meniscus in the aging patient
EISENBERG et al. Spontaneous Perforation of Umbilical Hernia: The Need for Early Herniorrhaphy in Ascites
Merrill Reversible renal failure
RU2039566C1 (en) Method for treating inflammatory and dystrophic diseases of mucous membranes of digestive organs
Keitzer Treatment of acute uremia
RU2290201C1 (en) Method for treating acute purulent-destructive pulmonary diseases
Riddell et al. Studies in Portal Hypertension
Ritchie Acute Peripheral Circulatory Failure in Surgical Cases
Shropshire et al. Suppression of Menstruation: A Hygienic Measure in the Care of Mentally Retarded Patients
RU2529414C1 (en) Method of treating patients suffering intrahepatic portal hypertension syndrome
Fang Peritoneal catheter perforating into the colon—a serious complication of peritoneal dialysis
Axelsen et al. Analgesics and the kidney
Sinha et al. 1195: CHICKEN POX WITH SEVERE SEPSIS WITH MULTI-ORGAN DYSFUNCTION AND SEVERE RHABDOMYOLYSIS
Bentley et al. 1194: NEUROTOXICITY ASSOCIATED WITH CEFEPIME DURING IHD AND THE EFFECT OF CVVHDF ON DRUG CLEARANCE
Howitt et al. 1192: OXYGENATION VIA BI-VENTRICULAR ASSIST DEVICE FOR EMERGENCY AIRWAY MANAGEMENT